Eliot M. Lurier
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Eliot M. Lurier
Eliot M. Lurier is recorded as CFO at Marker Therapeutics, Inc. (MRKR). Marker Therapeutics, Inc. reported in an 8-K filed November 20, 2023 that Eliot M. Lurier was terminated as Interim Chief Financial Officer and Principal Financial and Accounting Officer, effective November 17, 2023. Marker Therapeutics, Inc. reported in an 8-K filed July 3, 2023 that Eliot M. Lurier was appointed Interim Chief Financial Officer, effective June 30, 2023.
“On November 17, 2023, Mr. Lurier ceased serving as the Company’s Interim Chief Financial Officer and Principal Financial and Accounting Officer”
“Also effective June 30, 2023, the Company appointed Eliot M. Lurier as the Company's Interim Chief Financial Officer.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-06-30–present
-
2023-06-30–2023-11-17
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Marker Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Juan Vera CEO, COO, Board Member
- Juan Vera, M.D. COO
- Katharine Knobil, M.D. Board Member
- Kathryn Penkus Corzo Board Member
- Maria Bernadette Madel Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.